https://www.marketscreener.com/quote/stock/SURROZEN-INC-117468996/news/Surrozen-Inc-Initiates-Dosing-in-Phase-1-Clinical-Trial-of-SZN-043-for-Severe-Alcoholic-Hepatitis-40717843/?utm_source=telegram&utm_medium=social&utm_campaign=share